Bausch + Lomb reports positive 24-month trial data for glaucoma treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. TTEC
5. DAL
6. AWK
7. SPCX
8. III
9. TEVA
10. FCLI

Go back to Bausch + Lomb reports positive 24-month trial data for glaucoma treatment
(NYSE: BLCO) Delayed: 14.87 +0.01 (0.07%)
Previous Close $14.86    52 Week High $ 
Open $14.88    52 Week Low $ 
Day High $15.00    P/E N/A 
Day Low $14.82    EPS $ 
Volume 335,472